Tissue Genesis
Manufacturing · Hawaii, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
810 Richards St Ste 1000, Honolulu, Hawa...Phone Number
(808) 539-9331Website
www.tissuegenesis.comRevenue
<$5 MillionIndustry
About Tissue Genesis
Tissue Genesis specializes in advanced enzyme-derived cell processing solutions, particularly through their Icellator system, which efficiently extracts adult stem cells from adipose tissue. The Icellator is designed for point-of-care use, providing high stromal vascular fraction (SVF) cell yields in approximately 65 minutes and is currently approved for clinical use in The Bahamas, with ongoing FDA-approved studies in the USA. Their products are aimed at clinical staff in operating rooms, clinics, and research labs, ensuring a sterile and automated process for cell isolation. The company emphasizes high efficiency, minimal contamination risk, and compliance with FDA and ISO standards.Explore more
SIC Code 38,382NAICS Code 33,339Show moreTissue Genesis Org Chart
Compare Similar Companies to Tissue Genesis
Compare insights from companies similar to Tissue Genesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Tissue Genesis
<$5M
11-50
Private
-
2001
TC
Thomas CannonCo-Founder & Executive VP, Research Development & Director
Tissue Genesis Tech Stack
A closer look at the technologies used by Tissue Genesis
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tissue Genesis
Sign Up For FreeTo access detailed company insights
Tissue Genesis specializes in advanced enzyme-derived cell processing solutions, particularly through their Icellator system, which efficiently extracts adult stem cells from adipose tissue. The Icellator is designed for point-of-care use, providing high stromal vascular fraction (SVF) cell yields in approximately 65 minutes and is currently approv... Read More